MA27921A1 - Systemes emulsifiants contenant des derives d'azetidine - Google Patents

Systemes emulsifiants contenant des derives d'azetidine

Info

Publication number
MA27921A1
MA27921A1 MA28725A MA28725A MA27921A1 MA 27921 A1 MA27921 A1 MA 27921A1 MA 28725 A MA28725 A MA 28725A MA 28725 A MA28725 A MA 28725A MA 27921 A1 MA27921 A1 MA 27921A1
Authority
MA
Morocco
Prior art keywords
emulsifiing
systems containing
azetidine derivatives
containing azetidine
derivatives
Prior art date
Application number
MA28725A
Other languages
English (en)
Inventor
Sophie Cote
Maria-Teresa Peracchia
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MA27921A1 publication Critical patent/MA27921A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention a trait à des systèmes émulsifiants contenant des dérivés d'azétidine. La présente invention a trait à de nouvelles formulations de dérivés d'azétidine pour l'administration orale.
MA28725A 2003-07-18 2006-01-16 Systemes emulsifiants contenant des derives d'azetidine MA27921A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (fr) 2003-07-18 2003-07-18 Systèmes émulsifiants contenant des dérivés d'azétidine

Publications (1)

Publication Number Publication Date
MA27921A1 true MA27921A1 (fr) 2006-06-01

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28725A MA27921A1 (fr) 2003-07-18 2006-01-16 Systemes emulsifiants contenant des derives d'azetidine

Country Status (31)

Country Link
US (1) US20050037062A1 (fr)
EP (2) EP1498123A1 (fr)
JP (1) JP2009513559A (fr)
KR (1) KR20060040690A (fr)
CN (1) CN1822830A (fr)
AR (1) AR045912A1 (fr)
AU (1) AU2004262497A1 (fr)
BR (1) BRPI0412239A (fr)
CA (1) CA2532668A1 (fr)
CR (1) CR8178A (fr)
EC (1) ECSP066291A (fr)
GT (1) GT200400134A (fr)
HR (1) HRP20060021A2 (fr)
IL (1) IL173113A0 (fr)
MA (1) MA27921A1 (fr)
MX (1) MXPA06000478A (fr)
MY (1) MY142076A (fr)
NO (1) NO20060510L (fr)
NZ (1) NZ544707A (fr)
OA (1) OA13190A (fr)
PA (1) PA8606601A1 (fr)
PE (1) PE20050699A1 (fr)
RS (1) RS20050971A (fr)
RU (1) RU2348615C2 (fr)
SG (1) SG144140A1 (fr)
TN (1) TNSN06012A1 (fr)
TW (1) TW200522946A (fr)
UA (1) UA82539C2 (fr)
UY (1) UY28422A1 (fr)
WO (1) WO2005013972A1 (fr)
ZA (1) ZA200600489B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (fr) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Systèmes semi-solides contenant des dérivés d'azétidine
WO2007050574A1 (fr) * 2005-10-25 2007-05-03 Abbott Laboratories Preparation comprenant un medicament faiblement soluble dans l'eau et son procede d'utilisation
CN102159143A (zh) * 2006-09-29 2011-08-17 普拉罗美德公司 碎石术期间预防结石和结石碎片后退的方法
US8536208B2 (en) * 2007-08-21 2013-09-17 Basilea Pharmaceutica Ag Antifungal composition
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
CA2982162C (fr) 2015-04-10 2023-10-10 Bioresponse, L.L.C. Formulations auto-emulsifiantes d'indoles associes au dim
CN106551902B (zh) * 2015-09-17 2020-07-03 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
AU2018263868A1 (en) 2017-05-02 2019-12-12 Merck Sharp & Dohme Llc Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
US20240277615A1 (en) * 2021-06-11 2024-08-22 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
ECSP066291A (es) 2006-07-28
BRPI0412239A (pt) 2006-09-12
CN1822830A (zh) 2006-08-23
HRP20060021A2 (en) 2006-02-28
UY28422A1 (es) 2005-02-28
PA8606601A1 (es) 2005-03-03
CR8178A (es) 2007-12-04
EP1648441A1 (fr) 2006-04-26
US20050037062A1 (en) 2005-02-17
JP2009513559A (ja) 2009-04-02
MY142076A (en) 2010-08-30
AU2004262497A2 (en) 2005-02-17
OA13190A (en) 2006-12-13
AU2004262497A1 (en) 2005-02-17
ZA200600489B (en) 2007-04-25
PE20050699A1 (es) 2005-09-15
NZ544707A (en) 2009-01-31
TNSN06012A1 (en) 2007-10-03
WO2005013972A1 (fr) 2005-02-17
UA82539C2 (en) 2008-04-25
GT200400134A (es) 2005-02-22
NO20060510L (no) 2006-01-31
AR045912A1 (es) 2005-11-16
TW200522946A (en) 2005-07-16
SG144140A1 (en) 2008-07-29
RS20050971A (sr) 2008-06-05
IL173113A0 (en) 2006-06-11
RU2348615C2 (ru) 2009-03-10
EP1498123A1 (fr) 2005-01-19
RU2006105000A (ru) 2006-07-10
KR20060040690A (ko) 2006-05-10
CA2532668A1 (fr) 2005-02-17
MXPA06000478A (es) 2006-04-05

Similar Documents

Publication Publication Date Title
BR9902086A (pt) Formulações farmacêuticas.
CO5590918A2 (es) Formulaciones
MA27040A1 (fr) Nucleosides substitues en 4'
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
SE0302760D0 (sv) New compounds
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
NO20032208D0 (no) Benzodiazepinderivater som GABA A reseptormodulatorer
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
BR0211972A (pt) Composição oftálmica
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
NO20053398L (no) Farmasoytiske preparater av sertaconazol for vaginal anvendelse.
UY26851A1 (es) Derivados de la 4-fenilpiridina
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
HUP0101498A1 (hu) Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
DE60128100D1 (de) Analgetisches arzneimittel
MA27922A1 (fr) Formulations semi-solides de derives d'azetidine
PT1250125E (pt) Composicoes farmaceuticas contendo terbinafina
FR2861992B1 (fr) Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
ATE328595T1 (de) Carvedilolpolymorph
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
BR0312734A (pt) Composto de indolina e uso medicinal do mesmo
UY27823A1 (es) Nueva formulación para la administración parenteral de un bloqueante del canal del na